These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24487370)

  • 21. The hemodynamics of cirrhosis and the development of hepatorenal syndrome.
    Perkins J
    Liver Transpl; 2006 Jan; 12(1):162. PubMed ID: 16498712
    [No Abstract]   [Full Text] [Related]  

  • 22. Bile cast nephropathy.
    Jain K; Gupta A; Singh HK; Nickeleit V; Kshirsagar AV
    Kidney Int; 2015 Feb; 87(2):484. PubMed ID: 25635725
    [No Abstract]   [Full Text] [Related]  

  • 23. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 24. Cautious application of the hepatorenal syndrome criteria to critically ill patients with cirrhosis.
    Chen YW; Tsai CF; Wang TE; Chang CW; Pan CF; Wu CJ; Chen HH
    Liver Int; 2013 Jul; 33(6):959-60. PubMed ID: 23560886
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatorenal syndrome. Its clinical, paraclinical, therapeutic, evolutive and prognostic aspects].
    Pospai D; Oproiu C; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(6):561-73. PubMed ID: 2895951
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis and treatment of acute kidney injury and hepatorenal syndrome in patients with liver cirrhosis.
    Hu A; Jiang S; Hu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):193-9. PubMed ID: 29916656
    [No Abstract]   [Full Text] [Related]  

  • 27. Bile cast nephropathy due to cholestatic jaundice after using stanozolol in 2 amateur bodybuilders.
    Tabatabaee SM; Elahi R; Savaj S
    Iran J Kidney Dis; 2015 Jul; 9(4):331-4. PubMed ID: 26174462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research advances in pathophysiology and diagnosis and treatment of hepatorenal syndrome].
    Cui RB; Yan M
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):246-248. PubMed ID: 28494540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biliary lithogenic factors in the course of alcoholic liver cirrhosis].
    Cuglituri G; Maggioli G
    Minerva Dietol Gastroenterol; 1990; 36(2):91-3. PubMed ID: 2247265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of blood antioxidant enzymes in alcoholic cirrhosis.
    Chari S; Gupta M
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):343-6. PubMed ID: 14723322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.
    Ahn HS; Kim YS; Kim SG; Kim HK; Min SK; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS; Park JM
    Hepatogastroenterology; 2012 Jun; 59(116):1168-73. PubMed ID: 22057374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kidney diseases associated with liver cirrhosis].
    Nakamoto Y
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):67-72. PubMed ID: 1556465
    [No Abstract]   [Full Text] [Related]  

  • 34. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival.
    Barreto R; Fagundes C; Guevara M; Solà E; Pereira G; Rodríguez E; Graupera I; Martín-Llahí M; Ariza X; Cárdenas A; Fernández J; Rodés J; Arroyo V; Ginès P
    Hepatology; 2014 Apr; 59(4):1505-13. PubMed ID: 24037970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatorenal syndrome: incidence, predictive factors and prognosis].
    Moreau R
    Gastroenterol Clin Biol; 1994; 18(5):541-3. PubMed ID: 7813880
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatorenal syndrome.
    Cárdenas A; Gines P
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilirubin UDP-glucuronyltransferase activity of wistar rat kidney.
    Foliot A; Christoforov B; Petite JP; Etienne JP; Housset E; Dubois M
    Am J Physiol; 1975 Aug; 229(2):340-3. PubMed ID: 808968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.
    Durand F; Graupera I; Ginès P; Olson JC; Nadim MK
    Am J Kidney Dis; 2016 Feb; 67(2):318-28. PubMed ID: 26500178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice].
    Calès P; Boursier J; Oberti F; Gallois Y; Rousselet MC; Moal V; Macchi L; Chevailler A; Lunel F
    Pathol Biol (Paris); 2009 Sep; 57(6):459-62. PubMed ID: 19054629
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical analysis of 38 patients with hepatorenal syndrome].
    Wang Y; Cui Y; Jia JD; Ou XJ; Qian LX; Zhang FK; Yin SS; Zhao XY; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):628. PubMed ID: 14572349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.